A high-level overview of Passage Bio, Inc. (PASG) stock. View (PASG) real-time stock price, chart, news, analysis, analyst reviews and more.

In a turbulent market environment, Passage Bio Inc (PASG) stock has reached a new 52-week low, dipping to $0.3. With a market capitalization of just $19.33 million and a beta of 1.59 indicating ...

Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

PASG stock opened at $0.52 on Friday. Passage Bio has a 1 year low of $0.45 and a 1 year high of $1.79. The stock has a market capitalization of $32.00 million, a price-to-earnings ratio of -0.44 ...

Passage Bio Inc (PASG) stock has hit a 52-week low, trading at $0.55, as the company faces ongoing market headwinds. This latest price level reflects a significant downturn for the biotechnology ...

For PASG, shares are up 24.26% over the past week while the Zacks Medical - Biomedical and Genetics industry is up 3.78% over the same time period.